🇺🇸 CEFTAROLINE FOSAMIL ACETATE in United States

85 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Product Use In Unapproved Indication — 12 reports (14.12%)
  2. Off Label Use — 10 reports (11.76%)
  3. Treatment Failure — 10 reports (11.76%)
  4. Drug Ineffective — 9 reports (10.59%)
  5. General Physical Health Deterioration — 8 reports (9.41%)
  6. Hypophagia — 8 reports (9.41%)
  7. Staphylococcal Infection — 8 reports (9.41%)
  8. Thrombocytopenia — 8 reports (9.41%)
  9. Transaminases Increased — 8 reports (9.41%)
  10. Eosinophilia — 4 reports (4.71%)

Source database →

CEFTAROLINE FOSAMIL ACETATE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is CEFTAROLINE FOSAMIL ACETATE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for CEFTAROLINE FOSAMIL ACETATE in United States?

Marketing authorisation holder not available in our data.